Aspira Women's Health Inc. Quarterly Selling and Marketing Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Aspira Women's Health Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2010 to Q2 2024.
  • Aspira Women's Health Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $2.14M, a 20.6% increase year-over-year.
  • Aspira Women's Health Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $7.47M, a 33.3% decline year-over-year.
  • Aspira Women's Health Inc. annual Selling and Marketing Expense for 2023 was $7.81M, a 47.6% decline from 2022.
  • Aspira Women's Health Inc. annual Selling and Marketing Expense for 2022 was $14.9M, a 12.7% decline from 2021.
  • Aspira Women's Health Inc. annual Selling and Marketing Expense for 2021 was $17.1M, a 93.2% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.47M $2.14M +$365K +20.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $7.11M $1.89M -$706K -27.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $7.81M $1.74M -$1.15M -39.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $8.96M $1.7M -$2.25M -56.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $11.2M $1.77M -$1.81M -50.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $13M $2.6M -$1.9M -42.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $14.9M $2.89M -$1.99M -40.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $16.9M $3.95M -$1.13M -22.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $18M $3.58M -$438K -10.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $18.5M $4.5M +$1.39M +44.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $17.1M $4.88M +$2.03M +71.5% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-10-26
Q3 2021 $15.1M $5.08M +$2.93M +136% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $12.1M $4.02M +$2.29M +132% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $9.84M $3.11M +$993K +47% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $8.84M $2.84M +$767K +36.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $8.08M $2.15M -$273K -11.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $8.35M $1.73M -$1.05M -37.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $9.4M $2.12M -$249K -10.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $9.65M $2.08M +$480K +30.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $9.17M $2.43M +$1.08M +80.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $8.08M $2.78M +$1.3M +88.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $6.78M $2.36M +$1.14M +93% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $5.64M $1.6M +$442K +38.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-07
Q3 2018 $5.2M $1.34M +$293K +27.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $4.91M $1.48M +$437K +42% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $4.47M $1.23M +$202K +19.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $4.27M $1.15M -$130K -10.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $4.4M $1.05M -$556K -34.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $4.95M $1.04M -$587K -36.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $5.54M $1.02M -$1.26M -55.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $6.8M $1.28M -$1.31M -50.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 $8.11M $1.61M -$856K -34.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $8.97M $1.63M -$931K -36.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $9.9M $2.28M +$63K +2.84% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $9.83M $2.6M +$334K +14.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $9.5M $2.46M -$300K -10.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $9.8M $2.56M -$207K -7.48% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $10M $2.22M +$113K +5.37% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $9.89M $2.26M +$953K +72.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $8.94M $2.76M +$1.58M +134% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $7.36M $2.77M +$1.85M +201% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $5.51M $2.1M +$1.03M +96.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $4.48M $1.31M +$377K +40.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $4.1M $1.18M +$98K +9.06% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $4.01M $920K -$202K -18% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $4.21M $1.07M -$446K -29.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $4.65M $931K -$288K -23.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $4.94M $1.08M -$417K -27.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $5.36M $1.12M -$381K -25.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $5.74M $1.52M +$200K +15.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $5.54M $1.22M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 $1.5M +$474K +46.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $1.5M +$970K +182% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $1.32M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $1.03M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $533K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.